Xoft Inc., an electronic brachytherapy developer, showcases the expanded treatment capabilities of the Axxent eBx System. Xoft’s eBxtechnology delivers a high therapeutic dose to a cancer tumor while sparing nearby normal tissue.

Philips Healthcare offers the Panorama HFO magnetic resonance imaging system, which provides a 360-degree panoramic viewing angle and spacious 160 cm-wide patient aperture ensuring a comfortable, relaxing MRI experience for anxious, elderly, obese or claustrophobic patients.

Philips delivers time-of-flight (TOF) technology with its innovative TruFlight technology provided in its PET/CT systems. Philips TruFlight is TOF technology designed to improve image quality, especially for large patients, while it boosts procedure capacity. Now with 4D TOF available in the GEMINI TF Big Bore and the GEMINI TF, Philips continues to push the envelope of PET imaging performance.

Philips Brilliance CT Big Bore Oncology configuration builds on its AcQsim single-slice CT scanner. The Big Bore Oncology configuration offers oncologists an 85-cm bore that addresses patient positioning concerns and reaps the reward of high-speed, superior spatial resolution, all while providing 16 x 0.75 isotropic imaging.

Features and benefits:

Imagine being able to view vascular, soft tissue, bony, and abnormal structures at the same time is possible with Philips Healthcare's AcQSim³ workstation’s volume-rendered Digitally Composited Radiographs (DCRs). And AcQSim³‘s virtual fluoroscopy mode mimics the movement of a conventional fluoroscopic simulator – to permit fast target definition.

Philips Healthcare’s offers simulation and planning software to help advance intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT).

Known as GPS for the Body technology, the Calypso System utilizes miniature implanted Beacon transponders to provide precise, continuous, real-time information about the location of the tumor target during external beam radiation therapy. Any movement by the patient, including internal movement of the tumor, has the potential to compromise treatment accuracy.

September 29, 2009 - The campaign to pass the EARLY Act and raise awareness about breast cancer in young adult women generated momentum at a recent congressional reception on Capitol Hill.

September 29, 2009 - The Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc. (ProCure) announced plans to develop a proton therapy center in the Pacific Northwest.

September 29, 2009 - Worldwide sales of cancer drugs are forecast to increase at a compound annual growth rate of 12-15 percent from 2008, reaching US$75-80 billion by 2012.

Subscribe Now